Got children? How to get out the door on time

Despite valiant planning efforts and repeated requests, your children are half-dressed. They made the house look like a category F5 tornado came through, and are nowhere near ready to go when you need to get out the door. You can feel your temperature rising as the clock ticks toward late again. If this sounds familiar,… Read More »

FDA declines to approve Enzyvant regenerative therapy on manufacturing concerns

(Reuters) – Privately held drug developer Enzyvant said on Thursday the U.S. Food and Drug Administration declined to approve its regenerative tissue therapy for a rare immunodeficiency disorder and raised concerns about its manufacturing. The company was hoping to win its first approval for the therapy, RVT-802, aimed at treating congenital athymia, a disorder affecting… Read More »

Acadia Pharma’s psychosis drug proven better than placebo in dementia patients

(Reuters) – Acadia Pharmaceuticals Inc said on Wednesday dementia patients taking its drug Nuplazid were nearly three times less prone to a psychotic relapse than those on placebo. The drugmaker’s late-stage trial testing Nuplazid, stopped in September after positive results, enrolled 392 patients aged 74.5 years on average. Patients on the drug experienced a 65%… Read More »